BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

  February 10, 2025

   · 

  9 min read
• Press Releases

  IVIEW Therapeutics Announces Topline Results from Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe for Dry Eye Disease

  February 10, 2025

   · 

  3 min read
• Press Releases

  NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

  February 10, 2025

   · 

  5 min read
• Press Releases

  Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies

  February 10, 2025

   · 

  4 min read
• Press Releases

  Grace Therapeutics Announces Private Placement Financing of up to $30 Million

  February 10, 2025

   · 

  9 min read
• Press Releases

  GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders

  February 10, 2025

   · 

  9 min read
• Press Releases

  AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray

  February 10, 2025

   · 

  4 min read
• Press Releases

  Alterity Therapeutics Raises A$40.0 million in Placement

  February 10, 2025

   · 

  6 min read
• Press Releases

  Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma

  February 10, 2025

   · 

  18 min read
• Press Releases

  BioCryst to Report Fourth Quarter 2024 Financial Results on February 24

  February 10, 2025

   · 

  1 min read